Minocycline-induced autoimmune syndromes: an overview (Q28369204)

Seminars in Arthritis and Rheumatism

Europe PubMed Central

title

Minocycline-induced autoimmune syndromes: an overview (English)

0 references

author name string

O Elkayam

series ordinal

1

0 references

M Yaron

series ordinal

2

0 references

D Caspi

series ordinal

3

0 references

language of work or name

English

0 references

publication date

June 1999

0 references

published in

0 references

volume

28

0 references

issue

6

0 references

page(s)

392-7

0 references

cites work

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

1 reference

7 January 2021

Phototoxic Potential of Minocycline and Doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Hyperpigmentation associated with oral minocycline.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Late-onset drug fever associated with minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline pneumonitis and eosinophilia. A report on eight patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Serum sickness-like syndrome associated with minocycline therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Serum-sickness-like reaction associated with minocycline therapy in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Unusual systemic lupus erythematosus-like reaction to minocycline in a patient with acne and antecedent collagen disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-related lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-related lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Lupus-like syndrome associated with the use of minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-associated lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-induced lupus in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-related lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-related lupus in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Lupus-like syndrome in patients treated for acne

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Study of immune reactivity of minocycline-induced chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline-induced hepatitis with autoimmune features and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Minocycline and hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

The hepatotoxicity of intravenous aureomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

FATAL LIVER DISEASE AFTER INTRAVENOUS ADMINISTRATION OF TETRACYCLINE IN HIGH DOSAGE

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Tetracycline-associated fatty liver in the male. Report of an autopsied case

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Acute hepatitis and exfoliative dermatitis associated with minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Drugs associated with vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021

Hyperpigmentation, neutrophilic alveolitis, and erythema nodosum resulting from minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980004-3

7 January 2021